Jun 30, 2021

Arcturus Therapeutics Q2 2021 Earnings Report

Total Revenue
$2M
Previous year: $2.32M
-13.8%
EPS
-$2.07
Previous year: -$0.55
+276.4%
Gross Profit
$2M
Cash and Equivalents
$434M
Free Cash Flow
-$33.3M
Total Assets
$449M

Arcturus Therapeutics

Arcturus Therapeutics